BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30951642)

  • 1. Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension.
    Hudalla H; Michael Z; Christodoulou N; Willis GR; Fernandez-Gonzalez A; Filatava EJ; Dieffenbach P; Fredenburgh LE; Stearman RS; Geraci MW; Kourembanas S; Christou H
    Am J Respir Cell Mol Biol; 2019 Oct; 61(4):512-524. PubMed ID: 30951642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibition improves pulmonary artery reactivity and nitric oxide-mediated relaxation in sugen-hypoxia model of pulmonary hypertension.
    Christou H; Michael Z; Spyropoulos F; Chen Y; Rong D; Khalil RA
    Am J Physiol Regul Integr Comp Physiol; 2021 Jun; 320(6):R835-R850. PubMed ID: 33826428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase inhibitors and hypoxic pulmonary vasoconstriction.
    Swenson ER
    Respir Physiol Neurobiol; 2006 Apr; 151(2-3):209-16. PubMed ID: 16376158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hypoxia-induced calcium responses in pulmonary arterial smooth muscle by acetazolamide is independent of carbonic anhydrase inhibition.
    Shimoda LA; Luke T; Sylvester JT; Shih HW; Jain A; Swenson ER
    Am J Physiol Lung Cell Mol Physiol; 2007 Apr; 292(4):L1002-12. PubMed ID: 17209136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.
    Christou H; Hudalla H; Michael Z; Filatava EJ; Li J; Zhu M; Possomato-Vieira JS; Dias-Junior C; Kourembanas S; Khalil RA
    J Pharmacol Exp Ther; 2018 Feb; 364(2):258-274. PubMed ID: 29212831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
    Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
    J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vasodilating effect of acetazolamide and dorzolamide involves mechanisms other than carbonic anhydrase inhibition.
    Torring MS; Holmgaard K; Hessellund A; Aalkjaer C; Bek T
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):345-51. PubMed ID: 18757514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum-glucocorticoid regulated kinase 1 regulates macrophage recruitment and activation contributing to monocrotaline-induced pulmonary arterial hypertension.
    Xi X; Liu S; Shi H; Yang M; Qi Y; Wang J; Du J
    Cardiovasc Toxicol; 2014 Dec; 14(4):368-78. PubMed ID: 24825325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice.
    Batool M; Berghausen EM; Zierden M; Vantler M; Schermuly RT; Baldus S; Rosenkranz S; Ten Freyhaus H
    Basic Res Cardiol; 2020 Nov; 115(6):68. PubMed ID: 33188479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase is not a relevant nitrite reductase or nitrous anhydrase in the lung.
    Pickerodt PA; Kronfeldt S; Russ M; Gonzalez-Lopez A; Lother P; Steiner E; Vorbrodt K; Busch T; Boemke W; Francis RCE; Swenson ER
    J Physiol; 2019 Feb; 597(4):1045-1058. PubMed ID: 29660141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Macrophage Polarization Induces Experimental Pulmonary Hypertension and Is Observed in Patients With Pulmonary Arterial Hypertension.
    Zawia A; Arnold ND; West L; Pickworth JA; Turton H; Iremonger J; Braithwaite AT; Cañedo J; Johnston SA; Thompson AAR; Miller G; Lawrie A
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):430-445. PubMed ID: 33147993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of integrin-linked kinase in the hypoxia-induced phenotypic transition of pulmonary artery smooth muscle cells: Implications for hypoxic pulmonary hypertension.
    Hou J; Liu B; Zhu B; Wang D; Qiao Y; Luo E; Nawabi AQ; Yan G; Tang C
    Exp Cell Res; 2019 Sep; 382(2):111476. PubMed ID: 31255599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR2/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension.
    Abid S; Marcos E; Parpaleix A; Amsellem V; Breau M; Houssaini A; Vienney N; Lefevre M; Derumeaux G; Evans S; Hubeau C; Delcroix M; Quarck R; Adnot S; Lipskaia L
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31320454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the Aryl Hydrocarbon Receptor in Sugen 5416-induced Experimental Pulmonary Hypertension.
    Dean A; Gregorc T; Docherty CK; Harvey KY; Nilsen M; Morrell NW; MacLean MR
    Am J Respir Cell Mol Biol; 2018 Mar; 58(3):320-330. PubMed ID: 28956952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice.
    Shimizu T; Fukumoto Y; Tanaka S; Satoh K; Ikeda S; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2780-91. PubMed ID: 24135024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of acetazolamide and carbonic anhydrase inhibition on erythrocyte 2,3-diphosphoglycerate content and metabolism.
    Rolf LL; Garg LC
    J Pharmacol Exp Ther; 1975 May; 193(2):639-46. PubMed ID: 1142109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia induces pulmonary artery smooth muscle dysfunction through mitochondrial fragmentation-mediated endoplasmic reticulum stress.
    Zhuan B; Wang X; Wang MD; Li ZC; Yuan Q; Xie J; Yang Z
    Aging (Albany NY); 2020 Nov; 12(23):23684-23697. PubMed ID: 33221740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic nerve pH and PO2: the effects of carbonic anhydrase inhibition, and metabolic and respiratory acidosis.
    Pedersen DB; Stefánsson E; Kiilgaard JF; Jensen PK; Eysteinsson T; Bang K; la Cour M
    Acta Ophthalmol Scand; 2006 Aug; 84(4):475-80. PubMed ID: 16879567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Calpain-2 by Mediators in Pulmonary Vascular Remodeling of Pulmonary Arterial Hypertension.
    Kovacs L; Han W; Rafikov R; Bagi Z; Offermanns S; Saido TC; Black SM; Su Y
    Am J Respir Cell Mol Biol; 2016 Mar; 54(3):384-93. PubMed ID: 26248159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.